C12N 2533/56
Fibrin
Official title: Fibrin; Thrombin
C12N2533/56 (Fibrin) appears on 157 US grants and 349 published applications in this corpus.
Search patents in C12N- Granted patents
- 157
- Published applications
- 349
- Assignees
- 238
- Inventors
- 818
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 1 |
| 2002 | 1 | 9 |
| 2003 | 4 | 8 |
| 2004 | 3 | 7 |
| 2005 | 0 | 4 |
| 2006 | 4 | 17 |
| 2007 | 5 | 4 |
| 2008 | 4 | 10 |
| 2009 | 1 | 9 |
| 2010 | 3 | 15 |
| 2011 | 2 | 9 |
| 2012 | 4 | 16 |
| 2013 | 5 | 8 |
| 2014 | 13 | 8 |
| 2015 | 4 | 14 |
| 2016 | 3 | 11 |
| 2017 | 8 | 11 |
| 2018 | 6 | 16 |
| 2019 | 6 | 18 |
| 2020 | 8 | 25 |
| 2021 | 6 | 11 |
| 2022 | 5 | 23 |
| 2023 | 14 | 31 |
| 2024 | 1 | 28 |
| 2025 | 16 | 26 |
| 2026 | 8 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing cell aggregate1 Sep 2026US 12,723,236 B2Osaka University
- Method for freezing cell structure25 Aug 2026US 12,714,096 B2Kyoto Prefectural Public University Corporation
- Use of 3D-printed freestanding structures for ex vivo tissue21 Jul 2026US 12,688,798 B2The Regents of the University of California
- Generating populations of human blood and blood vessel progenitors from pluripotent stem cells14 Jul 2026US 12,680,077 B2The Board of Trustees of the Leland Stanford Junior University
- Extracellular matrix substitute in a cellular microcompartment16 Jun 2026US 12,655,383 B2Treefrog Therapeutics
- 3d bioprinting of structure cell aggregates and organoids20 Aug 2026US 2026/0241635 A1Carnegie Mellon University
- Insert for culturing tissue and method of culturing tissue using said insert2 Jul 2026US 2026/0185028 A1Nottingham Trent University
- Surface modified hydrogels comprising viable cells, methods of manufacture and use thereof2 Jul 2026US 2026/0185052 A1The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural
- Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase23 Apr 2026US 2026/0109783 A1Mesoblast, Inc.
- High-performance mature intestinal organoid regenerative therapeutic agent derived from pluripotent stem cells16 Apr 2026US 2026/0102434 A1Korea Research Institute of Bioscience and Biotechnology
Most cited
By later US patents
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Hybrid tissue scaffold for tissue engineering782US 8,815,594 B2Southwest Research Institute · 2014
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Repair of cartilage and bones372US 4,642,120 ARamot University Authority for Applied Research and Industrial Development Ltd. · 1987
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000